• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: UROPLASTY, LLC MACROPLASTIQUE IMPLANTS; AGENT, BULKING, INJECTABLE FOR GASTRO-UROLOGY USE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

UROPLASTY, LLC MACROPLASTIQUE IMPLANTS; AGENT, BULKING, INJECTABLE FOR GASTRO-UROLOGY USE Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Abdominal Pain (1685); Granuloma (1876)
Event Type  malfunction  
Manufacturer Narrative
Macroplastique implants are not indicated for treatment of vur within the united states (only female sui), however the vur inidication exists for all geographies outside the us.This event is being conservatively reported to fda as a) it was unclear based on the content of the published case study whether or not the mpq was reqmoved at the time of bladder stone removal and b) due to the fact that treatment with mpq for vur is similar to that for sui and therefore this type of event has the potential to occur within the us.Additionally, this report is being submitted to fda more than 30 days after the initial awareness date as the literature was published in (b)(4) and translations of the article were necessary in order to evalute whether or not the event described was reportable.
 
Event Description
This event was discovered during a literature search related to macroplastique (mpq) for treatment of vesicoureteral reflux (vur) and was found in the form of a case study.A (b)(6) year old man received mpq treatment for vur 7 years previous.Micturating cystourethrography had shown that the vur had disappeared.The patient presented with left abdominal pain as a main complaint.No hydronephrosis was shown in computer tomography however an approximately 8.3 mm sized stone was shown in the left vesicoureteral junction near where the mpq had been previously injected.Ureteral endoscopy showed a protuberant granulation tissue inside the bladder directly below the left ureteral orifice which was firmly attached to the stone.The stones were removed via holmium: yag laser, crushed and then removed from the patient's body.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MACROPLASTIQUE IMPLANTS
Type of Device
AGENT, BULKING, INJECTABLE FOR GASTRO-UROLOGY USE
Manufacturer (Section D)
UROPLASTY, LLC
5420 feltl road
minnetonka MN 55343
Manufacturer (Section G)
UROPLASTY, LLC
5420 feltl road
minnetonka MN 55343
Manufacturer Contact
nicole boser
5420 feltl road
minnetonka, MN 55343
9524266141
MDR Report Key8595744
MDR Text Key144824333
Report Number3002647932-2019-00003
Device Sequence Number1
Product Code LNM
Combination Product (y/n)N
Reporter Country CodeKS
PMA/PMN Number
P040050
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type literature
Reporter Occupation Other
Type of Report Initial
Report Date 05/08/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 03/28/2019
Initial Date FDA Received05/09/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age39 YR
-
-